S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
NYSE:RCUS

Arcus Biosciences News Headlines

$31.09
-1.28 (-3.95%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$31.06
$33.00
50-Day Range
$31.09
$48.47
52-Week Range
$22.36
$49.10
Volume
635,465 shs
Average Volume
759,698 shs
Market Capitalization
$2.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.85
Get Arcus Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Arcus Biosciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RCUS
News Sentiment

-0.01

0.40

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RCUS Articles
This Week

7

2

RCUS Articles
Average Week



Arcus Biosciences (NYSE:RCUS) News Headlines Today

SourceHeadline
MarketBeat logoArcus Biosciences, Inc. (NYSE:RCUS) Sees Significant Growth in Short Interest
americanbankingnews.com - January 20 at 11:10 AM
MarketBeat logoArcus Biosciences, Inc. (NYSE:RCUS) Expected to Announce Quarterly Sales of $8.87 Million
americanbankingnews.com - January 19 at 3:56 AM
MarketBeat logoZacks: Analysts Anticipate Arcus Biosciences, Inc. (NYSE:RCUS) Will Announce Earnings of -$1.13 Per Share
americanbankingnews.com - January 17 at 9:30 AM
finance.yahoo.com logoHedge Funds Are Selling Arcus Biosciences, Inc. (RCUS)
finance.yahoo.com - January 14 at 1:09 PM
MarketBeat logoThe Goldman Sachs Group Trims Arcus Biosciences (NYSE:RCUS) Target Price to $43.00
americanbankingnews.com - January 13 at 7:28 PM
MarketBeat logoArcus Biosciences (NYSE:RCUS) Shares Down 4.6%
americanbankingnews.com - January 12 at 1:42 PM
MarketBeat logoArcus Biosciences (NYSE:RCUS) Stock Rating Reaffirmed by SVB Leerink
americanbankingnews.com - January 12 at 6:50 AM
finance.yahoo.com logoArcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
finance.yahoo.com - January 10 at 12:01 PM
finance.yahoo.com logoArcus Biosciences Inc (RCUS) COO Jennifer Jarrett Sold $1.4 million of Shares
finance.yahoo.com - December 22 at 10:45 PM
finance.yahoo.com logoArcus Biosciences Inc (RCUS) COO Jennifer Jarrett Sold $508,641 of Shares
finance.yahoo.com - December 21 at 5:44 AM
finance.yahoo.com logoMyriad Genetics Promotes Nicole Lambert to Chief Operating Officer
finance.yahoo.com - December 14 at 7:33 PM
finance.yahoo.com logoWhy Arcus Biosciences Stock Vaulted Higher in November
finance.yahoo.com - December 9 at 9:57 AM
businesswire.com logoPrecision BioSciences to Host Virtual Webcast and Conference Call to Review Interim Phase 1/2a PBCAR0191 CAR T Data and Provide CAR T Program Updates on Saturday, December 11, 2021
businesswire.com - December 6 at 7:09 PM
nasdaq.com logoArcus Biosciences: Taiho Exercises Option For Exclusive License To Anti-TIGIT Program
nasdaq.com - November 30 at 10:26 AM
finance.yahoo.com logoArcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference
finance.yahoo.com - November 22 at 6:47 PM
finance.yahoo.com logoGilead (GILD) Exercises Options to Three Arcus Programs
finance.yahoo.com - November 19 at 1:01 PM
marketwatch.com logoArcus Biosciences Shares Rally as Gilead Exercises Options >RCUS
marketwatch.com - November 18 at 3:31 PM
finance.yahoo.com logoWhy Arcus Biosciences Stock Is On Fire Today
finance.yahoo.com - November 18 at 10:19 AM
businesswire.com logoPrecision BioSciences to Highlight Capabilities of ARCUS Gene Editing for Allogeneic CAR T Cell Immunotherapies at The Society for Immunotherapy of Cancer 36 th Annual Meeting
businesswire.com - November 10 at 10:48 AM
benzinga.com logoRecap: Arcus Biosciences Q3 Earnings
benzinga.com - November 8 at 9:16 PM
finance.yahoo.com logoArcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab
finance.yahoo.com - November 8 at 4:16 PM
finance.yahoo.com logoAre Investors Undervaluing Arcus Biosciences, Inc. (NYSE:RCUS) By 45%?
finance.yahoo.com - November 8 at 4:16 PM
markets.businessinsider.com logoWhat Wall Street expects from Arcus Biosciences's earnings
markets.businessinsider.com - November 7 at 6:13 PM
finance.yahoo.com logoArcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Highlights
finance.yahoo.com - November 2 at 5:05 PM
finance.yahoo.com logoEarnings Preview: Arcus Biosciences, Inc. (RCUS) Q3 Earnings Expected to Decline
finance.yahoo.com - October 28 at 7:34 PM
finance.yahoo.com logoHedge Funds Are Cashing Out Of Arcus Biosciences, Inc. (RCUS)
finance.yahoo.com - October 25 at 10:39 AM
nasdaq.com logoA Look At The Intrinsic Value Of Arcus Biosciences, Inc. (NYSE:RCUS)
nasdaq.com - October 18 at 7:33 PM
finance.yahoo.com logoPrecision BioSciences Appoints Michael Amoroso Chief Executive Officer
finance.yahoo.com - September 27 at 10:16 AM
bizjournals.com logoBay Area biotechs soar on coattails of AstraZeneca cancer drug study
bizjournals.com - September 17 at 7:05 PM
ca.finance.yahoo.com logoPrecision BioSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference
ca.finance.yahoo.com - September 10 at 7:06 AM
proactiveinvestors.com logoTiziana Life Sciences inks exclusive licensing deal with US group Precision BioSciences that takes it into CAR-T therapy
proactiveinvestors.com - September 2 at 4:19 AM
finance.yahoo.com logoArcus Biosciences to Participate at Upcoming Investor Conferences
finance.yahoo.com - September 1 at 6:18 PM
nasdaq.com logoRCUS Crosses Above Key Moving Average Level
nasdaq.com - August 30 at 5:59 PM
nasdaq.com logoDowngrade: Here's How Analysts See Arcus Biosciences, Inc. (NYSE:RCUS) Performing In The Near Term
nasdaq.com - August 10 at 9:35 AM
finance.yahoo.com logoThese Analysts Just Made A Substantial Downgrade To Their Arcus Biosciences, Inc. (NYSE:RCUS) EPS Forecasts
finance.yahoo.com - August 8 at 9:15 AM
finance.yahoo.com logoArcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 5 at 11:47 PM
finance.yahoo.com logoArcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights
finance.yahoo.com - August 5 at 6:41 PM
markets.businessinsider.com logoArcus Biosciences is about to announce its earnings — here's what to expect
markets.businessinsider.com - August 3 at 5:22 PM
msn.com logoGilead Sciences (GILD) Q2 2021 Earnings Call Transcript
msn.com - July 30 at 1:05 PM
finance.yahoo.com logoWill Arcus Biosciences, Inc. (RCUS) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 29 at 5:58 PM
finance.yahoo.com logoArcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights
finance.yahoo.com - July 29 at 5:58 PM
finance.yahoo.com logoArcus Surges As Executive Transfer Could Signal Deeper Gilead Partnership
finance.yahoo.com - July 20 at 2:31 PM
nasdaq.com logoFirst Week of RCUS September 17th Options Trading
nasdaq.com - July 16 at 3:18 PM
nasdaq.com logoArcus Biosciences (RCUS) Shares Cross Above 200 DMA
nasdaq.com - July 16 at 3:18 PM
finance.yahoo.com logoCan You Imagine How Jubilant Arcus Biosciences' (NYSE:RCUS) Shareholders Feel About Its 113% Share Price Gain?
finance.yahoo.com - July 2 at 3:04 PM
finance.yahoo.com logoArcus Biosciences, Inc. (RCUS) Stock Jumps 15.5%: Will It Continue to Soar?
finance.yahoo.com - June 25 at 12:22 PM
pricetargets.com logoArcus Biosciences Stock Surges With Gains Against Lung Cancer
pricetargets.com - June 25 at 10:12 AM
finance.yahoo.com logoWhy Arcus Biosciences' Big Reveal Wasn't Very Exciting
finance.yahoo.com - June 25 at 7:21 AM
marketwatch.com logoArcus Biosciences Shares Rise 15% on Positive Results for Lung-Cancer Treatment
marketwatch.com - June 24 at 4:17 PM
nasdaq.com logoHere's Why Arcus Biosciences Stock Is Rising Today
nasdaq.com - June 24 at 4:17 PM
Get Arcus Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.